Cargando…

Lung function impairment in lung cancer screening: discordance between risk and screening outcomes when looking through a PRISm

Detalles Bibliográficos
Autores principales:	Young, Robert P., Scott, Raewyn J., Gamble, Greg D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641039/ https://www.ncbi.nlm.nih.gov/pubmed/36386460 http://dx.doi.org/10.21037/tlcr-22-634

Ejemplares similares

Revisiting Peter Macklem's old dream through the PRISm of lung volumes
por: Ahmed, Engi, et al.
Publicado: (2023)

Fresnel Prism on Hess Screen Test
por: Koh, Kyung Min, et al.
Publicado: (2013)

Strange Bedfellows: The Interaction between COPD and Lung Cancer in the Context of Lung Cancer Screening
por: Silvestri, Gerard A., et al.
Publicado: (2020)

Looking at the Schizophrenia Spectrum Through the Prism of Self-disorders: An Empirical Study
por: Raballo, Andrea, et al.
Publicado: (2011)

When and how to Screen!
por: Ekbom, A.
Publicado: (2020)

Ultrasound in the critically ill: Look for Lung water!
por: Cho, Young-Jae
Publicado: (2014)

Cardiovascular Preparticipation Screening in Young Athletes: Looking Through One Lens
por: Asif, Irfan M., et al.
Publicado: (2016)

The Clinical Spectrum of PRISm
por: Wan, Emily S.
Publicado: (2022)

A Closer Look—Who Are We Screening for Lung Cancer?
por: Galang, Kristine, et al.
Publicado: (2023)

Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)
por: Kramer, Barnett S, et al.
Publicado: (2011)

Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism
por: Uversky, Vladimir N.
Publicado: (2017)

When alternatives to screening should be the priority
por: Wald, Nicholas J, et al.
Publicado: (2022)

Screening for disease, psychological testing, and psychotherapy Looking behind the mirror
por: Rao, T. S. Sathyanarayana, et al.
Publicado: (2013)

Saudi lung cancer prevention and screening guidelines
por: Howington, John
Publicado: (2018)

Lung cancer screening: are we performing it satisfactorily?
por: Minervini, Fabrizio, et al.
Publicado: (2023)

Looking beyond the cosmetic tattoo lesion near the eyebrow: Screening the lungs
por: Naeini, F Fatemi, et al.
Publicado: (2017)

GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?
por: Young, Robert P, et al.
Publicado: (2011)

PRISM: Fighting Against Open Access
por: Cairns, Linda
Publicado: (2007)

Evaluating the sustainability of a cancer screening intervention through a PRISM: The PreView experience
por: Walsh, Judith, et al.
Publicado: (2021)

Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study
por: Kaise, Toshihiko, et al.
Publicado: (2021)

Cost-effectiveness of computed tomography lung cancer screening
por: Reich, Jerome M
Publicado: (2009)

European Institute of Oncology project for lung cancer screening
por: Bellomi, Massimo
Publicado: (2015)

Pediatric eye screening – Why, when, and how
por: Honavar, Santosh G
Publicado: (2018)

Lessons Learned to Promote Lung Cancer Screening and Preempt Worsening Lung Cancer Disparities
por: Burnett-Hartman, Andrea N., et al.
Publicado: (2020)

Looking for solutions to lung dysfunction in type 2 diabetes
por: Simó, Rafael, et al.
Publicado: (2020)

Looking Higher: Is It Prime Time for the Oral–Lung Axis in HIV-related Lung Disease?
por: Huang, Yvonne J., et al.
Publicado: (2020)

Lung cancer screening: the preface
por: Snoeckx, Annemiek, et al.
Publicado: (2021)

The prescribing of prisms in clinical practice
por: Gray, Lyle S.
Publicado: (2008)

Delays in Follow-up after a Positive Lung Cancer Screening Exam: Is the Benefit of Screening Compromised?
por: Rivera, M. Patricia, et al.
Publicado: (2023)

Introducing Cambridge Prisms: Global Mental Health
por: Bass, Judy, et al.
Publicado: (2022)

Lung Cryobiopsy Versus Surgical Lung Biopsy for Diagnosing Fibrotic Interstitial Lung Disease: Still Looking for the “Perfect” Trial
por: Trisolini, Rocco
Publicado: (2023)

Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism
por: Redwan, Elrashdy M., et al.
Publicado: (2016)

Lung Cancer Screening: Subsequent Evidences of National Lung Screening Trial
por: Park, Young Sik
Publicado: (2014)

Circulating mitochondrial DNA as a biomarker for lung cancer screening
por: von Itzstein, Mitchell S., et al.
Publicado: (2022)

Are current lung cancer screening guidelines and programs racially biased?
por: Bonney, Asha, et al.
Publicado: (2023)

FAM13A locus in COPD is independently associated with lung cancer – evidence of a molecular genetic link between COPD and lung cancer
por: Young, Robert P, et al.
Publicado: (2010)

Toxoplasma gondii Tyrosine-Rich Oocyst Wall Protein: A Closer Look through an In Silico Prism
por: Asghari, Ali, et al.
Publicado: (2021)

Looking at the Pathogenesis of the Rabies Lyssavirus Strain Pasteur Vaccins through a Prism of the Disorder-Based Bioinformatics
por: Dhulipala, Surya, et al.
Publicado: (2022)

Potential Overdiagnosis with CT Lung Cancer Screening in Taiwanese Female: Status in South Korea
por: Goo, Jin Mo, et al.
Publicado: (2022)

Genetic evidence linking lung cancer and COPD: a new perspective
por: Young, Robert P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s0dl56417nlf95drvurn5rckn3